AudioCure Pharma GmbH
- Address
- Schlegelstrasse 9, Mitte
Sponsor Overview
Specializations
Otolaryngology and Hearing Disorders
AudioCure Pharma GmbH focuses on idiopathic sudden sensorineural hearing loss, with clinical research centered on the restoration of auditory function and the management of acute inner-ear injury. Its work is directed toward patients with moderately-severe to profound hearing loss and the evaluation of hearing recovery outcomes.
- Sudden sensorineural hearing loss
- Inner-ear hearing impairment
- Auditory threshold recovery
- Pure tone audiometry
The sponsor’s clinical activity is concentrated in hearing medicine and the treatment of acute auditory dysfunction, with research sites distributed across multiple European countries.
Middle Ear Therapeutics
Clinical interest extends to middle ear delivery approaches for hearing loss, reflecting a therapeutic focus on localized treatment of the auditory system. The funded research compares a single injection administered into the middle ear with an oral treatment option in the setting of sudden hearing loss.
- Middle ear administration
- Localized otic treatment
- Acute hearing restoration
This area highlights the sponsor’s involvement in therapies intended to address the affected ear directly in otologic disease.
Audiometric Outcome Assessment
Research activity includes measurement of hearing improvement through auditory threshold changes and frequency-specific testing. The clinical focus is on objective assessment of hearing performance after treatment in patients with sudden hearing loss.
- Hearing threshold change
- Frequency-based hearing testing
- Objective auditory assessment
These interests place emphasis on audiology as a core domain within the sponsor’s clinical research portfolio.
Safety and Tolerability in Ear Disease
The sponsor also investigates safety and tolerability in the context of treatment for sudden hearing loss, with attention to how therapies are used in patients experiencing acute auditory impairment.
- Therapeutic safety
- Tolerability evaluation
- Acute otologic treatment
This reflects a medical interest in ensuring that interventions for sensorineural hearing loss are suitable for use in the clinical management of ear-related disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Intratympanic AC102 Versus Oral Prednisolone in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized, Blinded, Phase II Study |  Austria Czechia Germany Poland The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 38 sites across their trial portfolio.
Therapeutic Focus
- 1.Otorhinolaryngologic Diseases1 trial49 other sponsors
Partnered Research Centres
38 centres- Address
- Nistelrodeseweg 10, 5406 PT Uden
- Address
- Warener Strasse 7, Biesdorf, 12683 Berlin
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
- Address
- Kwiatowa 1/1K, 85-047 Bydgoszcz
- Address
- Ul. Mokra 7, Kajetany, 05-830 Nadarzyn
- Address
- ul. Inflancka 4 A, 00-189 Warsaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to AudioCure Pharma GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.